This invention relates to novel compounds which are inhibitors of T790M containing EGFR mutants, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the prevention or treatment of cancer.
本发明涉及一种新型化合物,它们是T790M含有
EGFR突变体的
抑制剂,包括含有它们的制药组合物、它们的制备过程以及它们在预防或治疗癌症的治疗中的使用。